• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于识别心房颤动肺静脉隔离手术的当代行政代码。

Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation.

作者信息

Ferro Enrico G, Reynolds Matthew R, Xu Jiaman, Song Yang, Cohen David J, Wadhera Rishi K, d'Avila Andre, Zimetbaum Peter J, Yeh Robert W, Kramer Daniel B

机构信息

Richard A. and Susan F. Smith Center for Outcomes Research Beth Israel Deaconess Medical Center and Harvard Medical School Boston MA USA.

Division of Cardiovascular Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA USA.

出版信息

J Am Heart Assoc. 2025 Jan 21;14(2):e037003. doi: 10.1161/JAHA.124.037003. Epub 2025 Jan 10.

DOI:10.1161/JAHA.124.037003
PMID:39791397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12054420/
Abstract

BACKGROUND

Use of pulmonary vein isolation (PVI) to treat atrial fibrillation continues to increase. Despite great interest in leveraging administrative data for real-world analyses, contemporary procedural codes for identifying PVI have not been evaluated.

METHODS AND RESULTS

In this observational retrospective cohort study, inpatient PVIs were identified among US Medicare fee-for-service beneficiaries using Current Procedural Terminology (CPT) code 93656 in Carrier Line Files. Each patient was matched with their claims from Medicare Provider Analysis and Review to compare CPT with , , () claims submitted by health care facilities to bill for PVIs. We performed the reverse for commonly matched codes, to identify corresponding CPT-billed procedures. Finally, we reviewed institutional cases for additional comparison of CPT and assignation for PVI. We identified 25 617 inpatient PVIs from January 2017 to December 2021, of which 18 165 (71%) were linked to Medicare Provider Analysis and Review. Of these, 16 672 (92%) were billed as 02583ZZ: "Destruction of Conduction Mechanism, Percutaneous Approach." The reverse process yielded heterogeneous results: among 75 003 procedures billed as 02583ZZ, only 15 691 (21%) matched with CPT 93656 (PVI), as several other unrelated procedures were billed under this code. Institutional case review confirmed the greater specificity of CPT codes.

CONCLUSIONS

The code associated with CPT-billed PVI procedures actually referred to ablation of the atrioventricular junction. Yet this code also matched with a wide range of other procedures distinct from PVI. We conclude that codes alone are not sensitive nor specific for identifying PVI in claims and cannot be reliably used in isolation for health services research on this important procedure.

摘要

背景

肺静脉隔离术(PVI)用于治疗心房颤动的情况持续增加。尽管人们对利用行政数据进行真实世界分析兴趣浓厚,但用于识别PVI的当代程序编码尚未得到评估。

方法与结果

在这项观察性回顾性队列研究中,利用医保报销文件中的现行程序编码(CPT)93656在美国医疗保险按服务付费受益人群中识别住院患者的肺静脉隔离术。将每位患者与其医疗保险提供者分析与审查的理赔申请进行匹配,以比较CPT与医疗保健机构提交的用于PVI计费的[具体编码1]、[具体编码2]、[具体编码3]([具体编码名称])理赔申请。对于常见匹配的[具体编码名称]编码,我们进行反向操作,以识别相应的CPT计费程序。最后,我们审查机构病例,以进一步比较CPT与PVI的编码分配。我们在2017年1月至2021年12月期间识别出25617例住院患者的肺静脉隔离术,其中18165例(71%)与医疗保险提供者分析与审查相关联。在这些病例中,16672例(92%)被计费为02583ZZ:“经皮途径破坏传导机制”。反向操作产生了异质性结果:在75003例计费为02583ZZ的手术中,只有15691例(21%)与CPT 93656(肺静脉隔离术)匹配,因为在此编码下还计费了其他一些不相关的手术。机构病例审查证实了CPT编码具有更高的特异性。

结论

与CPT计费的PVI手术相关的[具体编码名称]编码实际上指的是房室结消融。然而,这个[具体编码名称]编码也与一系列不同于PVI的其他手术相匹配。我们得出结论,仅[具体编码名称]编码在理赔申请中识别PVI既不敏感也不特异,不能单独可靠地用于关于这一重要手术的卫生服务研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be96/12054420/8de1af6e39d6/JAH3-14-e037003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be96/12054420/8de1af6e39d6/JAH3-14-e037003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be96/12054420/8de1af6e39d6/JAH3-14-e037003-g001.jpg

相似文献

1
Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation.用于识别心房颤动肺静脉隔离手术的当代行政代码。
J Am Heart Assoc. 2025 Jan 21;14(2):e037003. doi: 10.1161/JAHA.124.037003. Epub 2025 Jan 10.
2
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
3
Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients: Temporal Trends and Clinical Outcomes.心力衰竭患者心房颤动消融的不同方法:时间趋势和临床结果。
JACC Clin Electrophysiol. 2025 May;11(5):942-952. doi: 10.1016/j.jacep.2024.12.004. Epub 2025 Jan 29.
4
Comparing mid-term outcomes of Cox-Maze procedure and pulmonary vein isolation for atrial fibrillation after concomitant mitral valve surgery: A systematic review.比较同期二尖瓣手术后行 Cox-Maze 手术与肺静脉隔离术治疗房颤的中期疗效:系统评价。
J Card Surg. 2022 Nov;37(11):3801-3810. doi: 10.1111/jocs.16888. Epub 2022 Aug 30.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.使用行政数据系统评价识别骨科植入物取出和翻修的验证方法。
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:265-73. doi: 10.1002/pds.2309.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Sex differences and risk factors for postoperative complications following catheter ablation for pulmonary vein isolation in non-valvular atrial fibrillation: A retrospective cohort study.非瓣膜性心房颤动患者肺静脉隔离导管消融术后的性别差异及术后并发症的危险因素:一项回顾性队列研究
Medicine (Baltimore). 2025 Jun 13;104(24):e42753. doi: 10.1097/MD.0000000000042753.
9
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Temporal trends and racial disparities in atrial fibrillation ablation: A 5-year study.心房颤动消融的时间趋势和种族差异:一项为期5年的研究。
J Arrhythm. 2025 Jun 3;41(3):e70104. doi: 10.1002/joa3.70104. eCollection 2025 Jun.

本文引用的文献

1
Outcomes of Atrial Fibrillation Ablation Among Older Adults in the United States: A Nationwide Study.美国老年人群心房颤动消融治疗结局:一项全国性研究。
JACC Clin Electrophysiol. 2024 Jul;10(7 Pt 1):1341-1350. doi: 10.1016/j.jacep.2024.03.032. Epub 2024 May 22.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
3
Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction.
有症状的器械相关静脉阻塞的发生率、治疗和结局。
J Am Coll Cardiol. 2023 Jun 20;81(24):2328-2340. doi: 10.1016/j.jacc.2023.04.017. Epub 2023 May 18.
4
Early mortality after inpatient versus outpatient catheter ablation in patients with atrial fibrillation.心房颤动患者住院与门诊导管消融术后早期死亡率。
Heart Rhythm. 2023 Jun;20(6):833-841. doi: 10.1016/j.hrthm.2023.02.016. Epub 2023 Feb 20.
5
The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.心房颤动患者节律控制作用的增加:JACC 现状述评。
J Am Coll Cardiol. 2022 May 17;79(19):1932-1948. doi: 10.1016/j.jacc.2022.03.337.
6
Accuracy of Administrative Claims Codes for Identifying Devices Used in Endovascular Femoropopliteal Artery Revascularisation: A Retrospective Observational Study at Two Tertiary Centres in the United States.用于识别血管腔内股腘动脉血运重建术中使用的器械的行政索赔代码准确性:美国两个三级中心的一项回顾性观察研究。
Eur J Vasc Endovasc Surg. 2022 May;63(5):769-770. doi: 10.1016/j.ejvs.2022.01.009. Epub 2022 Mar 17.
7
Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study.医疗保险受益人群中紫杉醇涂层器械治疗股腘动脉腔内治疗的安全性纵向评估:SAFE-PAD 研究。
JAMA Intern Med. 2021 Aug 1;181(8):1071-1080. doi: 10.1001/jamainternmed.2021.2738.
8
Rationale and Design of the SAFE-PAD Study.SAFE-PAD 研究的原理和设计。
Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e007040. doi: 10.1161/CIRCOUTCOMES.120.007040. Epub 2021 Jan 13.
9
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST).导管消融或药物治疗延缓心房颤动进展:随机对照心房颤动进展试验(ATTEST)。
Europace. 2021 Mar 8;23(3):362-369. doi: 10.1093/europace/euaa298.
10
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.冷冻球囊消融术作为心房颤动的初始治疗。
N Engl J Med. 2021 Jan 28;384(4):316-324. doi: 10.1056/NEJMoa2029554. Epub 2020 Nov 16.